Bausch Health Companies Inc.
BHC.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.43B | 10.16B | 9.92B | 9.74B | 9.62B |
| Total Other Revenue | 102.00M | 110.00M | 113.00M | 117.00M | 115.00M |
| Total Revenue | 10.53B | 10.27B | 10.03B | 9.86B | 9.73B |
| Cost of Revenue | 3.05B | 3.01B | 2.94B | 2.89B | 2.84B |
| Gross Profit | 7.48B | 7.25B | 7.09B | 6.97B | 6.89B |
| SG&A Expenses | 3.43B | 3.43B | 3.36B | 3.42B | 3.36B |
| Depreciation & Amortization | 986.00M | 1.00B | 1.02B | 1.05B | 1.06B |
| Other Operating Expenses | 1.00M | -- | -- | -- | -- |
| Total Operating Expenses | 8.12B | 8.07B | 7.96B | 7.96B | 7.87B |
| Operating Income | 2.42B | 2.19B | 2.07B | 1.90B | 1.86B |
| Income Before Tax | -940.00M | 367.00M | 520.00M | 281.00M | 189.00M |
| Income Tax Expenses | 285.00M | 247.00M | 199.00M | 233.00M | 270.00M |
| Earnings from Continuing Operations | -1.23K | 120.00 | 321.00 | 48.00 | -81.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 17.00M | 37.00M | 41.00M | 50.00M | 41.00M |
| Net Income | -1.21B | 157.00M | 362.00M | 98.00M | -40.00M |
| EBIT | 2.42B | 2.19B | 2.07B | 1.90B | 1.86B |
| EBITDA | 3.61B | 3.40B | 3.29B | 3.14B | 3.12B |
| EPS Basic | -3.24 | 0.42 | 0.97 | 0.26 | -0.11 |
| Normalized Basic EPS | 1.26 | 1.07 | 0.96 | 0.81 | 0.96 |
| EPS Diluted | -3.24 | 0.42 | 0.97 | 0.26 | -0.11 |
| Normalized Diluted EPS | 1.26 | 1.07 | 0.96 | 0.81 | 0.95 |
| Average Basic Shares Outstanding | 1.49B | 1.49B | 1.49B | 1.48B | 1.48B |
| Average Diluted Shares Outstanding | 1.49B | 1.49B | 1.49B | 1.48B | 1.48B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |